Who owns Champions Oncology?

Tip: Access positions for across all investors

Analyze quarterly positions in Champions Oncology with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Champions Oncology stock

Who bought or sold Champions Oncology this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Battery Management Corp. 2.4M $16M 0% Sep 2025
 View chart
NEA Management Company 1.7M $11M 0% Sep 2025
 View chart
Vanguard Group 333k $2.2M 2% Sep 2025
 View chart
Tocqueville Asset Management 320k $2.1M -20% Sep 2025
 View chart
Renaissance Technologies 167k $1.1M -8% Sep 2025
 View chart
Morgan Stanley 131k $962k 100% Jun 2025
 View chart
BlackRock 122k $789k 1% Sep 2025
 View chart
Geode Capital Management 74k $482k -1% Sep 2025
 View chart
Northern Trust 46k $301k -14% Sep 2025
 View chart
Acadian Asset Management 36k $232k 0% Sep 2025
 View chart
HighTower Advisors 35k $228k 0% Sep 2025
 View chart
Bank of New York Mellon 27k $173k 0% Sep 2025
 View chart
State Street Corporation 26k $170k 0% Sep 2025
 View chart
Dimensional Fund Advisors 24k $154k 6% Sep 2025
 View chart
Susquehanna International 20k $128k -63% Sep 2025
 View chart
Citadel Advisors 16k $106k 3% Sep 2025
 View chart
O'shaughnessy Asset Management 15k $94k -22% Sep 2025
 View chart
Millennium Management 13k $82k -47% Sep 2025
 View chart
Cambridge Investment Research Advisors 12k $79k 0% Sep 2025
 View chart
Mesirow Financial Investment Management International Equity 12k $78k 0% Sep 2025
 View chart
GSA Capital Partners 10k $67k 0% Sep 2025
 View chart
Royal Bank of Canada 6.6k $43k -14% Sep 2025
 View chart
Whittier Trust 800.00 $5.0k 100% Sep 2025
 View chart
Capital Advisors 48.00 $0 0% Sep 2025
 View chart
SBI Securities 16.00 $104.000000 -38% Sep 2025
 View chart
Jpmorgan Chase & Co 11.00 $70.999500 0% Sep 2025
 View chart
Garde Capital 1.00 $8.000000 0% Jun 2025
 View chart

Who sold out of Champions Oncology?

Fund or Company Name Date Sold Shares Held Valued At
Hillsdale Investment Management Jun 2025 25k $185k
Goldman Sachs Group Mar 2025 23k $201k
Jane Street Jun 2025 18k $130k
XTX Topco Jun 2025 14k $103k
Lazard Asset Management Jun 2025 1.3k $9.0k